title: Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics.
abstract: Prostate cancer (PCa) metastasizes to bone and soft tissues, greatly decreasing quality of life, causing bone pain, skeletal complications, and mortality in PCa patients. While new treatment strategies are being developed, the molecular and cellular basis of PCa metastasis and the "cross-talk" between cancer cells and their microenvironment and crucial cell signaling pathways need to be successfully dissected for intervention. In this review, we introduce a new concept of the mechanism of PCa metastasis, the recruitment and reprogramming of bystander and dormant cells (DCs) by a population of metastasis-initiating cells (MICs). We provide evidence that recruited and reprogrammed DCs gain MICs phenotypes and can subsequently metastasize to bone and soft tissues. We show that MICs can also recruit and reprogram circulating tumor cells (CTCs) and this could contribute to cancer cell evolution and the acquisition of therapeutic resistance. We summarize relevant molecular signaling pathways, including androgen receptors (ARs) and their variants and growth factors (GFs) and cytokines that could contribute to the predilection of PCa for homing to bone and soft tissues. To understand the etiology and the biology of PCa and the effectiveness of therapeutic targeting, we briefly summarize the animal and cell models that have been employed. We also report our experience in the use of three-dimensional (3-D) culture and co-culture models to understand cell signaling networks and the use of these attractive tools to conduct drug screening exercises against already-identified molecular targets. Further research into PCa growth and metastasis will improve our ability to target cancer metastasis more effectively and provide better rationales for personalized oncology.
authors.affiliation: 1 Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA ; 2 Australian Prostate Cancer Research Centre, Brisbane, Queensland 4102, Australia ; 3 Department of Surgery, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
authors.forename: Shabnam
authors.initials: S
authors.lastname: Ziaee
authors.affiliation: 1 Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA ; 2 Australian Prostate Cancer Research Centre, Brisbane, Queensland 4102, Australia ; 3 Department of Surgery, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
authors.forename: Gina Chia-Yi
authors.initials: GC
authors.lastname: Chu
authors.affiliation: 1 Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA ; 2 Australian Prostate Cancer Research Centre, Brisbane, Queensland 4102, Australia ; 3 Department of Surgery, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
authors.forename: Jen-Ming
authors.initials: JM
authors.lastname: Huang
authors.affiliation: 1 Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA ; 2 Australian Prostate Cancer Research Centre, Brisbane, Queensland 4102, Australia ; 3 Department of Surgery, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
authors.forename: Shirly
authors.initials: S
authors.lastname: Sieh
authors.affiliation: 1 Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA ; 2 Australian Prostate Cancer Research Centre, Brisbane, Queensland 4102, Australia ; 3 Department of Surgery, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
authors.forename: Leland W K
authors.initials: LW
authors.lastname: Chung
keywords: Metastasis-initiating cells (MICs); cell signaling network in tumor microenvironment; dormant cells (DCs); recruitment and reprogramming; three-dimensional cell culture
references.citation: Nature. 1994 Oct 20;371(6499):714-7
references.pmid: 7935819
references.citation: Cell. 2009 Jul 23;138(2):245-56
references.pmid: 19632176
references.citation: Science. 2002 Dec 6;298(5600):1911-2
references.pmid: 12471242
references.citation: Dev Biol. 2008 Apr 15;316(2):302-11
references.pmid: 18325490
references.citation: Cancer Res. 2013 Jan 15;73(2):483-9
references.pmid: 23117885
references.citation: Oncol Lett. 2012 Feb;3(2):395-400
references.pmid: 22740919
references.citation: Science. 2001 Nov 23;294(5547):1708-12
references.pmid: 11721053
references.citation: Cancer. 1997 Oct 15;80(8 Suppl):1588-94
references.pmid: 9362426
references.citation: Oncogene. 2008 Oct 6;27(45):5904-12
references.pmid: 18836471
references.citation: Nat Med. 2013 Nov;19(11):1423-37
references.pmid: 24202395
references.citation: Br J Cancer. 1988 Feb;57(2):174-7
references.pmid: 2833921
references.citation: Circ Res. 2007 Mar 30;100(6):782-94
references.pmid: 17395884
references.citation: J Biol Chem. 2011 Oct 14;286(41):36152-60
references.pmid: 21878636
references.citation: Nat Commun. 2013;4:1795
references.pmid: 23653207
references.citation: Genes Dev. 2010 Sep 15;24(18):1967-2000
references.pmid: 20844012
references.citation: J Endocrinol. 2011 May;209(2):139-51
references.pmid: 21307119
references.citation: J Cell Biochem. 2003 Jun 1;89(3):462-73
references.pmid: 12761880
references.citation: Semin Cancer Biol. 2008 Oct;18(5):356-64
references.pmid: 18472275
references.citation: Blood. 2002 Nov 1;100(9):3175-82
references.pmid: 12384415
references.citation: Curr Drug Targets. 2003 Apr;4(3):263-79
references.pmid: 12643476
references.citation: Curr Opin Hematol. 1995 Jan;2(1):61-7
references.pmid: 9371973
references.citation: J Cell Mol Med. 2011 Mar;15(3):635-46
references.pmid: 20184663
references.citation: Semin Cell Dev Biol. 2010 Feb;21(1):33-9
references.pmid: 19896548
references.citation: Cancer Res. 2011 Apr 1;71(7):2739-49
references.pmid: 21310825
references.citation: Genes Dev. 2008 Mar 1;22(5):559-74
references.pmid: 18316475
references.citation: Nature. 2003 May 15;423(6937):337-42
references.pmid: 12748652
references.citation: Br J Cancer. 1995 Oct;72(4):818-23
references.pmid: 7547226
references.citation: Cytokine. 2001 Jun 21;14(6):352-6
references.pmid: 11497497
references.citation: Science. 1999 Feb 5;283(5403):845-8
references.pmid: 9933168
references.citation: Nat Med. 2000 May;6(5):521-8
references.pmid: 10802707
references.citation: Immunobiology. 2004;209(1-2):11-20
references.pmid: 15481136
references.citation: Oncogene. 1999 Jul 22;18(29):4224-36
references.pmid: 10435635
references.citation: Endocr Relat Cancer. 2014 Mar 04;21(2):311-26
references.pmid: 24478054
references.citation: Prostate. 2000 Jul 1;44(2):91-103 Jul 1;44(2)
references.pmid: 10881018
references.citation: J Biol Chem. 1998 Nov 13;273(46):30336-43
references.pmid: 9804796
references.citation: Tissue Eng Part A. 2011 Mar;17(5-6):713-24
references.pmid: 20929283
references.citation: Mol Cancer. 2014 Sep 08;13:208
references.pmid: 25200184
references.citation: J Cell Sci. 2000 Jun;113 ( Pt 12):2139-47
references.pmid: 10825287
references.citation: Int J Biochem Cell Biol. 2001 Jan;33(1):33-44
references.pmid: 11167130
references.citation: Oncogene. 2008 Jul 3;27(29):4044-55
references.pmid: 18345028
references.citation: Cell. 1997 Apr 18;89(2):309-19
references.pmid: 9108485
references.citation: Cancer Res. 1996 Jul 1;56(13):3118-22
references.pmid: 8674070
references.citation: Biochim Biophys Acta. 2013 Apr;1835(2):170-9
references.pmid: 23287570
references.citation: Int J Oncol. 2004 Nov;25(5):1375-82
references.pmid: 15492828
references.citation: Cancers (Basel). 2012 May 29;4(2):531-48
references.pmid: 24213323
references.citation: N Engl J Med. 2005 Jul 14;353(2):172-87
references.pmid: 16014887
references.citation: FASEB J. 2003 Nov;17(14):2163-5
references.pmid: 14500543
references.citation: Endocr Relat Cancer. 1999 Sep;6(3):333-47
references.pmid: 10516850
references.citation: Science. 2001 Aug 10;293(5532):1068-70
references.pmid: 11498573
references.citation: Biochem Biophys Res Commun. 1993 Apr 30;192(2):940-7
references.pmid: 7683467
references.citation: Neoplasia. 2008 Aug;10(8):797-803
references.pmid: 18670640
references.citation: Eur J Immunol. 2011 Dec;41(12):3412-8
references.pmid: 22076814
references.citation: Cancer Res. 2008 Dec 15;68(24):10290-9
references.pmid: 19074897
references.citation: Cancer Res. 2008 Jun 15;68(12):4709-18
references.pmid: 18559517
references.citation: J Leukoc Biol. 1994 Oct;56(4):423-35
references.pmid: 7523556
references.citation: Cancer Res. 2013 Jun 1;73(11):3297-305
references.pmid: 23536554
references.citation: Mol Cancer. 2012 Sep 11;11:66
references.pmid: 22966907
references.citation: Curr Opin Genet Dev. 2004 Apr;14(2):188-95
references.pmid: 15196466
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Eur J Cancer. 2006 Feb;42(3):310-8
references.pmid: 16406506
references.citation: Am J Physiol Heart Circ Physiol. 2004 Sep;287(3):H1207-13
references.pmid: 15130893
references.citation: Cancer Res. 2013 May 1;73(9):2718-36
references.pmid: 23610450
references.citation: Cancer Manag Res. 2011;3:177-89
references.pmid: 21625400
references.citation: J Urol. 2005 Feb;173(2):342-59
references.pmid: 15643172
references.citation: Cancer Cell. 2003 Jun;3(6):537-49
references.pmid: 12842083
references.citation: Semin Cancer Biol. 2005 Oct;15(5):353-64
references.pmid: 15982899
references.citation: J Bone Miner Res. 2003 Feb;18(2):260-9
references.pmid: 12568403
references.citation: Cancer Cell. 2010 Feb 17;17(2):135-47
references.pmid: 20138012
references.citation: Cell. 1998 Apr 17;93(2):165-76
references.pmid: 9568710
references.citation: J Cell Biochem. 2006 Mar 1;97(4):661-72
references.pmid: 16447163
references.citation: Biochem Biophys Res Commun. 1990 Aug 16;170(3):998-1005
references.pmid: 2202304
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: J Biol Chem. 1997 Jun 13;272(24):15442-51
references.pmid: 9182576
references.citation: Annu Rev Cell Dev Biol. 2004;20:781-810
references.pmid: 15473860
references.citation: Trends Immunol. 2002 Nov;23(11):549-55
references.pmid: 12401408
references.citation: Genes Dev. 2013 Jul 15;27(14):1539-44
references.pmid: 23873937
references.citation: Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15152-7
references.pmid: 8986779
references.citation: Nat Med. 2007 Jul;13(7):791-801
references.pmid: 17618270
references.citation: Rev Endocr Metab Disord. 2001 Jan;2(1):105-15
references.pmid: 11704973
references.citation: Genes Dev. 2012 Jan 1;26(1):54-68
references.pmid: 22215811
references.citation: Oncogene. 2014 May 29;33(22):2815-25
references.pmid: 23752196
references.citation: J Cell Biol. 1995 Oct;131(2):539-49
references.pmid: 7593177
references.citation: N Engl J Med. 2014 Sep 11;371(11):1028-38
references.pmid: 25184630
references.citation: Nature. 2003 Oct 9;425(6958):577-84
references.pmid: 14534577
references.citation: Nat Genet. 1994 Jul;7(3):433-9
references.pmid: 7920665
references.citation: Nature. 2011 Dec 14;481(7380):190-4
references.pmid: 22170610
references.citation: J Steroid Biochem Mol Biol. 2004 Nov;92(4):221-36
references.pmid: 15663986
references.citation: J Cell Biochem Suppl. 1997;28-29:174-81
references.pmid: 9589364
references.citation: Nat Cell Biol. 2002 Apr;4(4):E83-90
references.pmid: 11944041
references.citation: Nat Methods. 2007 Apr;4(4):359-65
references.pmid: 17396127
references.citation: J Bone Miner Res. 2005 Feb;20(2):318-29
references.pmid: 15647826
references.citation: Cold Spring Harb Perspect Biol. 2011 Dec 01;3(12):null
references.pmid: 21917992
references.citation: Biochem Biophys Res Commun. 2005 Mar 18;328(3):679-87
references.pmid: 15694401
references.citation: J Invest Dermatol. 2004 Dec;123(6):1169-75
references.pmid: 15610530
references.citation: Nat Rev Mol Cell Biol. 2009 Dec;10(12):843-53
references.pmid: 19904298
references.citation: J Biol Chem. 1996 Nov 22;271(47):30022-7
references.pmid: 8939948
references.citation: J Clin Invest. 2005 Nov;115(11):2979-91
references.pmid: 16239969
references.citation: Blood. 2003 Nov 1;102(9):3262-9
references.pmid: 12855577
references.citation: Nat Rev Cancer. 2001 Oct;1(1):34-45
references.pmid: 11900250
references.citation: Clin Exp Metastasis. 2009;26(1):35-49
references.pmid: 18814043
references.citation: Clin Cancer Res. 2006 Mar 15;12(6):1665-71
references.pmid: 16551847
references.citation: Curr Opin Endocrinol Diabetes Obes. 2010 Apr;17(2):120-5
references.pmid: 20150806
references.citation: Nat Rev Cancer. 2003 Dec;3(12):952-9
references.pmid: 14737125
references.citation: Cell. 2002 Sep 20;110(6):673-87
references.pmid: 12297042
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3540-5
references.pmid: 10097072
references.citation: J Nutr Biochem. 2009 Dec;20(12):917-26
references.pmid: 19733471
references.citation: Cancer Res. 2009 Mar 15;69(6):2305-13
references.pmid: 19244107
references.citation: Cancer Res. 2005 Jun 15;65(12):5278-83
references.pmid: 15958574
references.citation: Science. 1997 May 30;276(5317):1425-8
references.pmid: 9162012
references.citation: Urology. 1995 Mar;45(3):542-9
references.pmid: 7879350
references.citation: Nat Rev Cancer. 2008 Aug;8(8):618-31
references.pmid: 18633355
references.citation: Nat Rev Cancer. 2001 Oct;1(1):46-54
references.pmid: 11900251
references.citation: Cell. 2011 Mar 4;144(5):782-95
references.pmid: 21376238
references.citation: Cell. 2014 Sep 25;159(1):176-87
references.pmid: 25201530
references.citation: Clin Cancer Res. 1997 Dec;3(12 Pt 1):2493-500
references.pmid: 9815652
references.citation: Endocr Rev. 1998 Feb;19(1):18-54
references.pmid: 9494779
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14821-6
references.pmid: 9843973
references.citation: Urology. 2002 Dec;60(6):1113-7
references.pmid: 12475693
references.citation: Neoplasia. 2008 Apr;10(4):314-29
references.pmid: 18392133
references.citation: Am J Pathol. 1995 Aug;147(2):386-96
references.pmid: 7639332
references.citation: Exp Cell Res. 2012 Nov 15;318(19):2507-19
references.pmid: 22841689
references.citation: Prostate. 2014 Sep;74(12 ):1199-208
references.pmid: 25043157
references.citation: Br J Cancer. 1997;76(9):1134-8
references.pmid: 9365160
references.citation: Lancet. 2001 Feb 17;357(9255):539-45
references.pmid: 11229684
references.citation: Nat Genet. 2001 Oct;29(2):117-29
references.pmid: 11586292
references.citation: Trends Genet. 2002 May;18(5):S1-5
references.pmid: 12047956
references.citation: Hum Pathol. 2000 May;31(5):578-83
references.pmid: 10836297
references.citation: Clin Cancer Res. 2006 Mar 1;12(5):1420-30
references.pmid: 16533764
references.citation: Histol Histopathol. 2006 Aug;21(8):857-65
references.pmid: 16691538
references.citation: Prostate Cancer. 2011;2011:895238
references.pmid: 22111002
references.citation: Am J Physiol Cell Physiol. 2001 Jun;280(6):C1375-86
references.pmid: 11350732
references.citation: Nature. 1998 Jan 15;391(6664):285-8
references.pmid: 9440692
references.citation: Trends Endocrinol Metab. 2010 May;21(5):315-24
references.pmid: 20138542
references.citation: Development. 2007 Dec;134(23):4177-86
references.pmid: 17959718
references.citation: Nat Rev Cancer. 2004 Jan;4(1):71-8
references.pmid: 14708027
references.citation: Pathol Int. 2010 Jul;60(7):497-505
references.pmid: 20594270
references.citation: J Natl Cancer Inst. 1994 Feb 2;86(3):238
references.pmid: 8283498
references.citation: Nature. 2009 Nov 26;462(7272):505-9
references.pmid: 19940926
references.citation: Front Genet. 2013 Dec 31;4:305
references.pmid: 24427166
references.citation: Oral Dis. 2014 Oct;20(7):682-92
references.pmid: 24118341
references.citation: Nat Rev Clin Oncol. 2011 Jan;8(1):12-23
references.pmid: 20859283
references.citation: Dev Dyn. 2004 Sep;231(1):122-7
references.pmid: 15305292
references.citation: Clin Exp Metastasis. 2008;25(6):601-10
references.pmid: 18535913
references.citation: Int J Cancer. 2007 Oct 1;121(7):1463-72
references.pmid: 17546601
references.citation: Nature. 2004 Nov 18;432(7015):332-7
references.pmid: 15549095
references.citation: Adv Exp Med Biol. 1992;324:173-82
references.pmid: 1492615
references.citation: Methods Mol Med. 2003;81:21-39
references.pmid: 12725112
references.citation: Cell. 2009 Nov 25;139(5):891-906
references.pmid: 19931152
references.citation: Genes Dev. 1999 May 15;13(10 ):1297-308
references.pmid: 10346818
references.citation: Nature. 2007 Jun 21;447(7147):966-71
references.pmid: 17515920
references.citation: Oncol Rep. 2011 Nov;26(5):1243-50
references.pmid: 21725611
references.citation: Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S67-74
references.pmid: 14600594
references.citation: Biochem J. 2003 Aug 15;374(Pt 1):1-20
references.pmid: 12773095
references.citation: Nat Rev Cancer. 2005 Sep;5(9):675-88
references.pmid: 16148884
references.citation: Oncogene. 2012 Mar 1;31(9):1130-42
references.pmid: 21804603
references.citation: J Cell Biol. 1997 Apr 7;137(1):231-45
references.pmid: 9105051
references.citation: Nature. 1996 Aug 15;382(6592):635-8
references.pmid: 8757135
references.citation: Curr Opin Cell Biol. 2003 Dec;15(6):753-62
references.pmid: 14644202
references.citation: Exp Cell Res. 2013 Jan 1;319(1):75-87
references.pmid: 23022396
references.citation: In Vitro Cell Dev Biol Anim. 2001 Mar;37(3):127-40
references.pmid: 11370803
references.citation: J Immunol. 2005 May 15;174(10):6477-89
references.pmid: 15879151
references.citation: Trends Immunol. 2004 Jun;25(6):280-8
references.pmid: 15145317
references.citation: Cancer Res. 2008 Jul 1;68(13):5469-77
references.pmid: 18593950
references.citation: Cell. 2010 Apr 2;141(1):39-51
references.pmid: 20371344
references.citation: Mol Endocrinol. 2005 Dec;19(12):2943-54
references.pmid: 16081517
references.citation: Cancer Res. 1991 Jun 1;51(11):3059-61
references.pmid: 2032246
references.citation: J Exp Med. 2001 Mar 19;193(6):727-40
references.pmid: 11257139
references.citation: Clin Cancer Res. 2000 Mar;6(3):1190-7
references.pmid: 10741751
references.citation: Cancer. 2004 Nov 15;101(10 Suppl):2371-490
references.pmid: 15495199
references.citation: Lab Invest. 1996 Jan;74(1):43-7
references.pmid: 8569196
references.citation: PLoS One. 2011;6(12):e28670
references.pmid: 22205960
references.citation: Cancer Res. 1985 Sep;45(9):4200-5
references.pmid: 4028010
references.citation: Clin Cancer Res. 2012 Jan 15;18(2):326-35
references.pmid: 22031096
references.citation: Cell. 1994 Apr 22;77(2):261-71
references.pmid: 7513258
references.citation: J Clin Invest. 1999 Jan;103(2):197-206
references.pmid: 9916131
references.citation: J Clin Oncol. 2005 Mar 20;23(9):2078-93
references.pmid: 15774796
references.citation: Curr Opin Genet Dev. 2009 Feb;19(1):67-73
references.pmid: 19211240
references.citation: Cancer Cell. 2012 Mar 20;21(3):309-22
references.pmid: 22439926
references.citation: Cancer Metastasis Rev. 2014 Sep;33(2-3):497-509
references.pmid: 24398859
references.citation: Cancer Res. 2002 Mar 15;62(6):1832-7
references.pmid: 11912162
references.citation: J Immunol. 2007 Mar 1;178(5):2623-9
references.pmid: 17312100
references.citation: J Nucl Med. 2010 Apr;51(4):501-4
references.pmid: 20237033